Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington’s disease decades before clinical motor diagnosis
Nature Medicine · 2025-03 · 31 (3) · 807-818
DOI: 10.1038/s41591-024-03424-6 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nature Medicine, online erschienen am 17.01.2025. Verfasst von Rachael I Scahill und 32 weiteren Autor:innen. Beteiligte Einrichtung: Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK. Hauptthemen laut MEDLINE: Huntingtin Protein, Huntington Disease, Trinucleotide Repeat Expansion. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust (Wellcome), CHDI Foundation.
Abstract (Originalsprache)
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disease with the age at which characteristic symptoms manifest strongly influenced by inherited HTT CAG length. Somatic CAG expansion occurs throughout life and understanding the impact of somatic expansion on neurodegeneration is key to developing therapeutic targets. In 57 HD gene expanded (HDGE) individuals, ~23 years before their predicted clinical motor diagnosis, no significant decline in clinical, cognitive or neuropsychiatric function was observed over 4.5 years compared with 46 controls (false discovery rate (FDR) > 0.3). However, cerebrospinal fluid (CSF) markers showed very early signs of neurodegeneration in HDGE with elevated neurofilament light (NfL) protein, an indicator of neuroaxonal damage (FDR = 3.2 × 10 −12 ), and reduced proenkephalin (PENK), a surrogate marker for the state of striatal medium spiny neurons (FDR = 2.6 × 10 −3 ), accompanied by brain atrophy, predominantly in the caudate (FDR = 5.5 × 10 −10 ) and putamen (FDR = 1.2 × 10 −9 ). Longitudinal increase in somatic CAG repeat expansion ratio (SER) in blood was a significant predictor of subsequent caudate (FDR = 0.072) and putamen (FDR = 0.148) atrophy. Atypical loss of interruption HTT repeat structures, known to predict earlier age at clinical motor diagnosis, was associated with substantially faster caudate and putamen atrophy. We provide evidence in living humans that the influence of CAG length on HD neuropathology is mediated by somatic CAG repeat expansion. These critical mechanistic insights into the earliest neurodegenerative changes will inform the design of preventative clinical trials aimed at modulating somatic expansion. ClinicalTrials.gov registration: NCT06391619 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
- Department of Psychiatry, University of Cambridge, Cambridge, UK.
- School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.
- Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
- Department of Computer Science and Centre for Medical Image Computing, University College London, London, UK.
Förderung
- Medical Research Council
- Wellcome Trust (Wellcome)
- CHDI Foundation
Zitieren
APA
Scahill, R. I., Farag, M., Murphy, M. J., Hobbs, N. Z., Leocadi, M., Langley, C., Knights, H., Ciosi, M., Fayer, K., Nakajima, M., Thackeray, O., Gobom, J., Rönnholm, J., Weiner, S., Hassan, Y. R., Ponraj, N. K. P., Estevez-Fraga, C., Parker, C. S., Malone, I. B., …, & Tabrizi, S. J. (2025). Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington’s disease decades before clinical motor diagnosis. Nature Medicine, 31(3), 807-818. https://doi.org/10.1038/s41591-024-03424-6
Vancouver
Scahill RI, Farag M, Murphy MJ, Hobbs NZ, Leocadi M, Langley C, et al. Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington’s disease decades before clinical motor diagnosis. Nature Medicine. 2025;31(3):807-818. doi:10.1038/s41591-024-03424-6
BibTeX
@article{Scahill2025,
author = {Scahill, Rachael I and Farag, Mena and Murphy, Michael J and Hobbs, Nicola Z and Leocadi, Michela and Langley, Christelle and Knights, Harry and Ciosi, Marc and Fayer, Kate and Nakajima, Mitsuko and Thackeray, Olivia and Gobom, Johan and Rönnholm, John and Weiner, Sophia and Hassan, Yara R and Ponraj, Nehaa K P and Estevez-Fraga, Carlos and Parker, Christopher S and Malone, Ian B and Hyare, Harpreet and Long, Jeffrey D and Heslegrave, Amanda and Sampaio, Cristina and Zhang, Hui and Robbins, Trevor W and Zetterberg, Henrik and Wild, Edward J and Rees, Geraint and Rowe, James B and Sahakian, Barbara J and Monckton, Darren G and Langbehn, Douglas R and Tabrizi, Sarah J},
title = {Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington’s disease decades before clinical motor diagnosis},
journal = {Nature Medicine},
year = {2025},
volume = {31},
number = {3},
pages = {807--818},
doi = {10.1038/s41591-024-03424-6}
}
EUVIMED